[Treatment of hearing disorders using Cosaldon retard].
D000368:Aged; D001921:Brain / Q000378:metabolism; D002560:Cerebrovascular Circulation / Q000187:drug effects; D005260:Female; D006311:Hearing Disorders / Q000188:drug therapy*; D006320:Hearing Tests; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D014786:Vision Disorders / Q000188:drug therapy; D014801:Vitamin A / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use*
D009539:Nicotinic Acids; D014970:Xanthines; D014801:Vitamin A; D014810:Vitamin E
Behandlung der Schwerhörigkeit mit Cosaldon retard.